Selective PPAR-Delta/PPAR-Gamma Activation Improves Cognition in a Model of Alzheimer’s Disease

Background: The continuously increasing association of Alzheimer’s disease (AD) with increased mortality rates indicates an unmet medical need and the critical need for establishing novel molecular targets for therapeutic potential. Agonists for peroxisomal proliferator activating receptors (PPAR) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Steinke, Ian, Govindarajulu, Manoj, Pinky, Priyanka Das, Bloemer, Jenna, Yoo, Sieun, Ward, Tracey, Schaedig, Taylor, Young, Taylor, Wibowo, Fajar Setyo, Suppiramaniam, Vishnu, Amin, Rajesh H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136457/
https://www.ncbi.nlm.nih.gov/pubmed/37190025
http://dx.doi.org/10.3390/cells12081116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136457/
https://www.ncbi.nlm.nih.gov/pubmed/37190025
http://dx.doi.org/10.3390/cells12081116

Ejemplares similares